The hearing of New Horizon Health's (HKG:6606) joint provisional liquidator application with the Grand Court of the Cayman Islands has been scheduled at 10 am on Aug. 6, a Friday Hong Kong bourse filing said.
The cancer screening test developer had filed the application in early July.
If appointed, the joint provisional liquidators will conduct investigations into the firm's affairs, in particular, certain concerns raised by the company's auditors in relation to its 2023 annual results.
The auditor raised questions on the validity of certain sales transactions, as well as marketing and selling expenses among other things, according to a March 2024 disclosure.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.